Phase III Randomized Trial of Docetaxel Plus Cisplatin Versus Vindesine Plus Cisplatin in Patients With Stage IV Non-Small-Cell Lung Cancer: The Japanese Taxotere Lung Cancer Study Group

KUBOTA, Kaoru ; WATANABE, Koshiro ; YONEDA, Shuichi ; MATSUI, Kaoru ; KUDO, Shinzo ; SHIBUYA, Masahiko ; ISOBE, Takeshi ; SEGAWA, Yoshihiko ; NISHIWAKI, Yutaka ; OHASHI, Yasuo ; NIITANI, Hisanobu ; KUNITOH, Hideo ; NODA, Kazumasa ; ICHINOSE, Yukito ; KATAKAMI, Nobuyuki ; SUGIURA, Takahiko ; KAWAHARA, Masaaki ; YOKOYAMA, Akira ; YOKOTA, Soichiro

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Impact of IGF-I and CYP19 Gene Polymorphisms on the Survival of Patients With Metastatic Prostate Cancer

TSUCHIYA, Norihiko ; LIZHONG WANG ; OGAWA, Osamu ; NAKAMURA, Akira ; HABUCHI, Tomonori ; SUZUKI, Hiroyoshi ; SEGAWA, Takehiko ; FUKUDA, Hisami ; NARITA, Shintaro ; SHIMBO, Masaki ; KAMOTO, Toshiyuki ; MITSUMORI, Kenji ; ICHIKAWA, Tomohiko

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

EGFR ligands and ERCC1 mRNA expression to predict clinical outcome in Japanese (JPN) patients (pts) with metastatic colorectal cancer (mCRC) harboring overexpressed EGFR and KRAS exon 2 wild-type ( KRAS wt) treated with cetuximab (cet) plus oxaliplatin-based chemotherapy (JACCRO CC-05/06 AR)

Sunakawa, Yu ; Ichikawa, Wataru ; Tsuji, Akihito ; Moran, Miriana ; Astrow, Stephanie H. ; Yang, Dongyun ; Zhang, Wu ; Takahashi, Takehiro ; Denda, Tadamichi ; Shimada, Ken ; Kochi, Mitsugu ; Nakamura, Masato ; Kotaka, Masahito ; Segawa, Yoshihiko ; Takeuchi, Masahiro ; Lenz, Heinz-Josef ; Fujii, Masashi ; Nakajima, Toshifusa

Texto completo disponível

Impacts of T and N factors on curability of pancreatic, gastric, and colonic cancers

Maetani, S. ; Segawa, Y. ; Banja, H. ; Obayashi, H. ; Imamura, M. ; Gamel, J. W.

Texto completo disponível

A randomized phase III study of cisplatin and docetaxel with or without irinotecan in pts with advanced non-small cell lung cancer: Okayama Lung Cancer Study Group OLCSG 0403

Kiura, K. ; Tabata, M. ; Takigawa, N. ; Kuyama, S. ; Segawa, Y. ; Kamei, H. ; Shibayama, T. ; Hotta, K. ; Matsuo, K. ; Tanimoto, M.

Texto completo disponível

A randomized phase II study of a combination of docetaxel and S-1 versus docetaxel monotherapy in pts with NSCLC previously treated with platinum-based chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) trial 0503

Segawa, Y. ; Hotta, K. ; Takigawa, N. ; Matsuo, K. ; Yoshioka, H. ; Hayashi, H. ; Nogami, N. ; Tabata, M. ; Kiura, K. ; Tanimoto, M.

Texto completo disponível

Randomized phase III trial of docetaxel and cisplatin combination chemotherapy versus mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer: OLCSG 0007

Kiura, K. ; Takigawa, N. ; Segawa, Y. ; Kamei, H. ; Takemoto, M. ; Tabata, M. ; Ueoka, H. ; Hiraki, S. ; Matsuo, K. ; Tanimoto, M.

Texto completo disponível

A phase II trial of combination chemotherapy with irinotecan and amrubicin in pretreated patients with non-small cell lung cancer

Segawa, Y. ; Nogami, N. ; Shinkai, T. ; Kiura, K. ; Tabata, M. ; Takigawa, N. ; Hotta, K. ; Shibayama, T. ; Ueoka, H. ; Tanimoto, M.

Sem texto completo

Randomized phase III trial of docetaxel and cisplatin combination chemotherapy versus mitomycin, vindesine and cisplatin combination chemotherapy with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer: Preliminary report

Kiura, K. ; Segawa, Y. ; Tabata, M. ; Takigawa, N. ; Kamei, H. ; Harita, S. ; Ueoka, H. ; Hiraki, S. ; Matsuo, K. ; Tanimoto, M.

Sem texto completo

Clinical factors affecting the late resistance to gefitinib in patients with non-small cell lung cancer (NSCLC)

Segawa, Y. ; Hotta, K. ; Umemura, S. ; Fujiwara, Y. ; Shinkai, T. ; Ueoka, H. ; Takigawa, N. ; Tabata, M. ; Kiura, K. ; Tanimoto, M.

Sem texto completo